Glenmark wraps up diabetic drug trials
Glenmark Pharmaceuticals has completed its pre-clinical trials for a new anti-diabetic and anti-obesity drug titled GRC 1087 in animals. The company has already filed for patents which would be
Glenmark Pharmaceuticals has completed its pre-clinical trials for a new anti-diabetic and anti-obesity drug titled GRC 1087 in animals. The company has already filed for patents which would be